Quarterly Call Option Transactions in Viridian Therapeutics, Inc.\De (VRDN)
This table provides information about the institutional ownership of Viridian Therapeutics, Inc.\De (VRDN) during . The information is specifically focused on institutions that hold call options of Viridian Therapeutics, Inc.\DE.
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 0 | 58,200 | 58,200 | — | 58,200 | |||
| Q4 2021 | 10,500 | 0 | 10,500 | 0 | 2,500 | 2,500 | 8,000 | |
| Q1 2022 | 13,800 | 20,000 | 33,800 | — | 33,800 | |||
| Q2 2022 | 11,700 | 354,700 | 366,400 | 7,100 | 0 | 7,100 | 359,300 | |
| Q3 2022 | 10,900 | 0 | 10,900 | 19,100 | 0 | 19,100 | -8,200 | |
| Q4 2022 | 2,100 | 22,600 | 24,700 | 53,100 | 0 | 53,100 | -28,400 | |
| Q1 2023 | 7,300 | 222,464 | 229,764 | 7,000 | 0 | 7,000 | 222,764 | |
| Q2 2023 | 99,900 | 144,000 | 243,900 | — | 243,900 | |||
| Q3 2023 | 0 | 3,900 | 3,900 | 11,800 | 0 | 11,800 | -7,900 | |
| Q4 2023 | 17,000 | 25,800 | 42,800 | 301 | 0 | 301 | 42,499 | |
| Q1 2024 | 67,500 | 45,000 | 112,500 | 2,000 | 0 | 2,000 | 110,500 | |
| Q2 2024 | 1,200 | 29,900 | 31,100 | 9,100 | 0 | 9,100 | 22,000 | |
| Q3 2024 | 231,100 | 220,000 | 451,100 | 3,100 | 0 | 3,100 | 448,000 | |